The global Epidermal Growth Factors (EGFs) market is poised for robust expansion, reaching a projected value of US$ 3.7 billion by 2034, up from US$ 1.1 billion in 2023, growing at a compound annual growth rate (CAGR) of 11.3% between 2024 and 2034. The market is experiencing dynamic transformations due to rapid technological innovations, a rise in chronic disease incidence, and increased...